BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30091296)

  • 1. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
    Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
    Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.
    Stine JG; Shah NL; Argo CK; Pelletier SJ; Caldwell SH; Northup PG
    Liver Transpl; 2015 Aug; 21(8):1016-21. PubMed ID: 25845711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis.
    Molinari M; Fernandez-Carrillo C; Dai D; Dana J; Clemente-Sanchez A; Dharmayan S; Kaltenmeier C; Liu H; Behari J; Rachakonda V; Ganesh S; Hughes C; Tevar A; Al Harakeh H; Emmanuel B; Humar A; Bataller R
    Transpl Int; 2021 Jun; 34(6):1105-1122. PubMed ID: 33780554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
    Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
    Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors associated with portal vein thrombosis in pediatric living donor liver transplant recipients.
    Neto JS; Fonseca EA; Feier FH; Pugliese R; Candido HL; Benavides MR; Porta G; Miura IK; Danesi VB; Guimaraes T; Porta A; Borges C; Godoy A; Kondo M; Chapchap P
    Liver Transpl; 2014 Oct; 20(10):1157-67. PubMed ID: 24954288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.
    Stine JG; Argo CK; Pelletier SJ; Maluf DG; Northup PG
    Transpl Int; 2016 Dec; 29(12):1286-1295. PubMed ID: 27714853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.
    Gaballa D; Bezinover D; Kadry Z; Eyster E; Wang M; Northup PG; Stine JG
    Liver Transpl; 2019 Dec; 25(12):1747-1755. PubMed ID: 31436367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular mortality among liver transplant recipients with nonalcoholic steatohepatitis in the United States-a retrospective study.
    Satapathy SK; Jiang Y; Eason JD; Kedia SK; Wong E; Singal AK; Tolley EA; Hathaway D; Nair S; Vanatta JM
    Transpl Int; 2017 Oct; 30(10):1051-1060. PubMed ID: 28622441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States.
    Waits SA; Wojcik BM; Cai S; Mathur AK; Englesbe MJ
    Liver Transpl; 2011 Sep; 17(9):1066-72. PubMed ID: 21744467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplant recipients with portal vein thrombosis: a single center retrospective study.
    Tao YF; Teng F; Wang ZX; Guo WY; Shi XM; Wang GH; Ding GS; Fu ZR
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):34-9. PubMed ID: 19208512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.
    Linares I; Goldaracena N; Rosales R; Maza L; Kaths M; Kollmann D; Echeverri J; Selzner N; McCluskey SA; Sapisochin G; Lilly LB; Greig P; Bhat M; Ghanekar A; Cattral M; McGilvray I; Grant D; Selzner M
    Liver Transpl; 2018 Sep; 24(9):1209-1220. PubMed ID: 30146768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation.
    Cavalcante ACBS; Zurstrassen CE; Carnevale FC; Pugliese RPS; Fonseca EA; Moreira AM; Matushita JPK; Cândido HLL; Benavides MAR; Miura IK; Danesi VLB; Hirschfeld APM; Borges CBV; Porta G; ChapChap P; Seda-Neto J
    Am J Transplant; 2018 Sep; 18(9):2220-2228. PubMed ID: 30019834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
    Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
    Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein thrombosis in biliary atresia patients after living donor liver transplantation.
    Ou HY; Concejero AM; Huang TL; Chen TY; Tsang LL; Chen CL; Yu PC; Yu CY; Cheng YF
    Surgery; 2011 Jan; 149(1):40-7. PubMed ID: 20570300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.